Operating Lease, Right-of-Use Asset of Vitro Biopharma, Inc. from 31 Oct 2022 to 31 Oct 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of lessee's right to use underlying asset under operating lease.
Summary: Vitro Biopharma, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Oct 2022 to 31 Oct 2025.
Vitro Biopharma, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Oct 2025 was $360,681, a 25% decline year-over-year.
Source SEC data: View on sec.gov

Operating Lease, Right-of-Use Asset, Quarterly (USD)

Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Vitro Biopharma, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2025	$360,681	-$121,144	-25%	31 Oct 2025	10-K	13 Feb 2026	2025	FY
Q2 2025	$255,658	-$122,139	-32%	31 Jul 2025	10-Q	12 Sep 2025	2025	Q3
Q1 2025	$285,130	-$124,770	-30%	30 Apr 2025	10-Q	20 Jun 2025	2025	Q2
Q4 2024	$315,209	-$127,425	-29%	31 Jan 2025	10-Q	20 Mar 2025	2025	Q1
Q3 2024	$481,825	+$5,584	+1.2%	31 Oct 2024	10-K	13 Feb 2026	2025	FY
Q2 2024	$377,797	+$106,401	+39%	31 Jul 2024	10-Q	16 Sep 2024	2024	Q3
Q1 2024	$409,900	+$158,206	+63%	30 Apr 2024	10-Q	31 May 2024	2024	Q2
Q4 2023	$442,634	+$178,266	+67%	31 Jan 2024	10-Q	14 Mar 2024	2024	Q1
Q3 2023	$476,241	+$198,860	+72%	31 Oct 2023	10-K	28 Jan 2025	2024	FY
Q2 2023	$271,396			31 May 2023	10-K	13 Feb 2026	2025	FY
Q1 2023	$251,694			30 Apr 2023	10-Q	13 Jun 2023	2023	Q2
Q4 2022	$264,368			31 Jan 2023	10-Q	14 Mar 2023	2023	Q1
Q3 2022	$277,381			31 Oct 2022	10-K	29 Jan 2024	2023	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.